CSPC Pharmaceutical Group Limited (FRA:CVG)

Market Cap	10.28B
Revenue (ttm)	3.45B
Net Income (ttm)	534.62M
Shares Out	n/a
EPS (ttm)	0.05
PE Ratio	19.22
Forward PE	16.43
Dividend	0.03 (3.70%)
Ex-Dividend Date	Jun 4, 2025

Volume	4,250
Average Volume	3,371
Open	0.8156
Previous Close	0.8216
Day's Range	0.8156 - 0.8156
52-Week Range	0.5108 - 1.0040
Beta	n/a
RSI	51.15
Earnings Date	Aug 20, 2025

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma,...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 21,400
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CVG

Financial Performance

In 2024, CSPC Pharmaceutical Group's revenue was 29.01 billion, a decrease of -7.76% compared to the previous year's 31.45 billion. Earnings were 4.33 billion, a decrease of -26.31%.

Financial numbers in CNY